Diego Sangiorgi

Author PubWeight™ 29.74‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis. Lancet 2012 4.02
2 Interventricular delay interval optimization in cardiac resynchronization therapy guided by echocardiography versus guided by electrocardiographic QRS interval width. Am J Cardiol 2008 1.99
3 Systemic cardiac amyloidoses: disease profiles and clinical courses of the 3 main types. Circulation 2009 1.93
4 Stent thrombosis with everolimus-eluting stents: meta-analysis of comparative randomized controlled trials. Circ Cardiovasc Interv 2012 1.89
5 Impact of bifurcation technique on 2-year clinical outcomes in 773 patients with distal unprotected left main coronary artery stenosis treated with drug-eluting stents. Circ Cardiovasc Interv 2008 1.60
6 Phrenic stimulation: a challenge for cardiac resynchronization therapy. Circ Arrhythm Electrophysiol 2009 1.26
7 Risk of stroke with coronary artery bypass graft surgery compared with percutaneous coronary intervention. J Am Coll Cardiol 2012 1.11
8 Ostial and midshaft lesions vs. bifurcation lesions in 1111 patients with unprotected left main coronary artery stenosis treated with drug-eluting stents: results of the survey from the Italian Society of Invasive Cardiology. Eur Heart J 2009 1.04
9 Longevity of implantable cardioverter-defibrillators: implications for clinical practice and health care systems. Europace 2008 1.00
10 Reliability and validity of two four-level emergency triage systems. Eur J Emerg Med 2009 0.96
11 Risk factors for diagnostic delay in acute aortic dissection. Am J Cardiol 2008 0.92
12 A randomised study comparing the antiplatelet and antiinflammatory effect of clopidogrel 150 mg/day versus 75 mg/day in patients with ST-segment elevation acute myocardial infarction and poor responsiveness to clopidogrel: results from the DOUBLE study. Thromb Res 2009 0.86
13 Two-year clinical outcome with drug-eluting stents versus bare-metal stents in a real-world registry of unprotected left main coronary artery stenosis from the Italian Society of Invasive Cardiology. Am J Cardiol 2008 0.85
14 Reliability and validity of an Italian four-level emergency triage system. Emerg Med J 2010 0.84
15 Appraising the impact of left ventricular ejection fraction on outcomes of percutaneous drug-eluting stenting for unprotected left main disease: insights from a multicenter registry of 975 patients. Clin Res Cardiol 2010 0.83
16 Clown intervention to reduce preoperative anxiety in children and parents: a randomized controlled trial. J Health Psychol 2013 0.82
17 Accuracy of oxygen uptake efficiency slope in adults with congenital heart disease. Int J Cardiol 2008 0.82
18 Strong and independent prognostic value of peak circulatory power in adults with congenital heart disease. Am Heart J 2007 0.82
19 Sex-related differences in patients undergoing percutaneous unprotected left main stenting. EuroIntervention 2010 0.81
20 How many hypertensive patients can be controlled in "real life": an improvement strategy in primary care. BMC Fam Pract 2013 0.81
21 Impact of acute coronary syndromes on two-year clinical outcomes in patients with unprotected left main coronary artery stenosis treated with drug-eluting stents. Am J Cardiol 2010 0.78
22 [Achievement of therapeutic target in subjects on statin treatment in clinical practice. Results of the STAR (Statins Target Assessment in Real practice) study]. Monaldi Arch Chest Dis 2011 0.78
23 Temporal pattern of ischemic events in relation to dual antiplatelet therapy in patients with unprotected left main coronary artery stenosis undergoing percutaneous coronary intervention. J Am Coll Cardiol 2009 0.78
24 NT pro-B-type natriuretic peptide levels are related to microvascular reperfusion in patients undergoing direct percutaneous transluminal coronary angioplasty for anterior ST-segment elevation myocardial infarction. J Cardiovasc Med (Hagerstown) 2010 0.77
25 Importance and limits of pre-hospital electrocardiogram in patients with ST elevation myocardial infarction undergoing percutaneous coronary angioplasty. Eur J Cardiovasc Prev Rehabil 2011 0.76
26 Receipt of adjuvant systemic therapy among patients with high-risk breast cancer detected by mammography screening. Breast Cancer Res Treat 2008 0.76
27 Prognostic implications of ST-segment elevation resolution in patients with ST-segment elevation acute myocardial infarction treated with primary or facilitated percutaneous coronary intervention. Am J Cardiol 2010 0.76
28 Analysis of disease patterns and cost of treatments for prevention of deep venous thrombosis after total knee or hip replacement: results from the Practice Analysis of THromboprophylaxis after Orthopaedic Surgery (PATHOS) study. Clinicoecon Outcomes Res 2012 0.75
29 Is time on cardiopulmonary bypass during cardiac surgery associated with acute kidney injury requiring dialysis? Hemodial Int 2012 0.75
30 Defining high-risk patients with ST-segment elevation acute myocardial infarction undergoing primary percutaneous coronary intervention: a comparison among different scoring systems and clinical definitions. Int J Cardiol 2011 0.75